{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:49:36Z","timestamp":1779173376284,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Caffeine use in preterm infants has endured several paradigms: from standard of care to possible neurotoxin to one of the few medications for which there is evidence of bronchopulmonary dysplasia (BPD) risk reduction. The purpose of the review is to analyze this dynamic trajectory and discuss controversies that still remain after decades of caffeine use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Following concerns for caffeine safety in preterm infants, a large randomized controlled trial demonstrated a reduction in BPD and treatment for patent ductus arteriosus. The lower rate of death or neurodevelopmental impairment noted at 18\u201321 months was not statistically different at later timepoints; however, infants in the caffeine group had lower rates of motor impairment at 11-year follow-up. The time of caffeine therapy initiation is now substantially earlier, and doses used are sometimes higher that previously used, but there are limited data to support these practices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Caffeine therapy for apnea of prematurity (AOP) remains one of the pillars of neonatal care, although more evidence to support dosing and timing of initiation and discontinuation are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000588","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T20:21:36Z","timestamp":1516220496000},"page":"177-181","source":"Crossref","is-referenced-by-count":16,"title":["Caffeine controversies"],"prefix":"10.1097","volume":"30","author":[{"given":"Samuel J.","family":"Gentle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colm P.","family":"Travers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"CD000140","article-title":"Methylxanthine treatment for apnoea in preterm infants","author":"Henderson-Smart","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpeds.2016.11.081","article-title":"The longitudinal effects of persistent apnea on cerebral oxygenation in infants born preterm","volume":"182","author":"Horne","year":"2017","journal-title":"J Pediatr"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jamapediatrics.2014.2223","article-title":"Association of early caffeine administration and neonatal outcomes in very preterm neonates","volume":"169","author":"Lodha","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3476(99)70180-0","article-title":"Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?","volume":"135","author":"Schmidt","year":"1999","journal-title":"J Pediatr"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpeds.2015.04.040","article-title":"The effect of caffeine on diaphragmatic activity and tidal volume in preterm infants","volume":"167","author":"Kraaijenga","year":"2015","journal-title":"J Pediatr"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuro.2016.11.012","article-title":"Caffeine for apnea of prematurity: effects on the developing brain","volume":"58","author":"Atik","year":"2017","journal-title":"Neurotoxicology"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/j.1651-2227.2012.02664.x","article-title":"Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity","volume":"101","author":"Kumral","year":"2012","journal-title":"Acta Paediatr"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1651-2227.2010.01828.x","article-title":"Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants?","volume":"99","author":"Tracy","year":"2010","journal-title":"Acta Paediatr"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpeds.2009.10.033","article-title":"Caffeine increases cerebral cortical activity in preterm infants","volume":"156","author":"Supcun","year":"2010","journal-title":"J Pediatr"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.siny.2003.11.008","article-title":"Controversies surrounding xanthine therapy","volume":"9","author":"Millar","year":"2004","journal-title":"Semin Neonatol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0028-3908(97)00139-1","article-title":"Neonatal cerebral hypoxia\u2013ischemia: the effect of adenosine receptor antagonists","volume":"36","author":"Bona","year":"1997","journal-title":"Neuropharmacology"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.21008","article-title":"Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury","volume":"60","author":"Back","year":"2006","journal-title":"Ann Neurol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000278840","article-title":"Protective effects of methylxanthines on hypoxia-induced apoptotic neurodegeneration and long-term cognitive functions in the developing rat brain","volume":"98","author":"Kumral","year":"2010","journal-title":"Neonatology"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1440-1754.2000.00446.x","article-title":"Methylxanthines and sensorineural outcome at 14 years in children < 1501\u200ag birthweight","volume":"36","author":"Davis","year":"2000","journal-title":"J Paediatr Child Health"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1136\/fn.83.1.F39","article-title":"Metabolic and respiratory effects of theophylline in the preterm infant","volume":"83","author":"Carnielli","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1542\/peds.107.4.660","article-title":"Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea","volume":"107","author":"Bauer","year":"2001","journal-title":"Pediatrics"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2011.2024","article-title":"Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity","volume":"307","author":"Schmidt","year":"2012","journal-title":"JAMA"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapediatrics.2017.0238","article-title":"Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial","volume":"171","author":"Schmidt","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jpeds.2009.09.069","article-title":"Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups","volume":"156","author":"Davis","year":"2010","journal-title":"J Pediatr"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/pr.2015.72","article-title":"A pilot randomized trial of high-dose caffeine therapy in preterm infants","volume":"78","author":"McPherson","year":"2015","journal-title":"Pediatr Res"},{"key":"R27-20230918","first-page":"CD000432","article-title":"Prophylactic methylxanthine for prevention of apnoea in preterm infants","author":"Henderson-Smart","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/14767058.2014.885941","article-title":"Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants","volume":"27","author":"Taha","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jpeds.2013.12.025","article-title":"Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants","volume":"164","author":"Dobson","year":"2014","journal-title":"J Pediatr"},{"key":"R30-20230918","first-page":"45","article-title":"Apnea of prematurity: caffeine dose optimization","volume":"18","author":"Francart","year":"2013","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1754.2010.01943.x","article-title":"Caffeine citrate for very preterm infants: effects on development, temperament and behaviour","volume":"47","author":"Gray","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1542\/peds.2008-2568","article-title":"Infant functional status: the timing of physiologic maturation of premature infants","volume":"123","author":"Bakewell-Sachs","year":"2009","journal-title":"Pediatrics"},{"issue":"(3 Pt 1)","key":"R33-20230918","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1542\/peds.100.3.354","article-title":"Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks","volume":"100","author":"Eichenwald","year":"1997","journal-title":"Pediatrics"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1542\/peds.2010-1567","article-title":"Epidemiology of apnea and bradycardia resolution in premature infants","volume":"128","author":"Lorch","year":"2011","journal-title":"Pediatrics"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2015-3757","article-title":"Apnea of prematurity","volume":"137","author":"Eichenwald","year":"2016","journal-title":"Pediatrics"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.4371","article-title":"Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial","volume":"168","author":"Rhein","year":"2014","journal-title":"JAMA Pediatr"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201804000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:13:03Z","timestamp":1695003183000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201804000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000588","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}